期刊文献+

倍半萜内酯类天然产物抗肿瘤活性及机制研究进展 被引量:2

Advance in antitumor activity and mechanism of natural sesquiterpene lactones
下载PDF
导出
摘要 恶性肿瘤是威胁人类生命健康主要因素之一。抗肿瘤药物的研发一直是热点和重点。天然产物历来是新药的重要来源,倍半萜内酯类化合物是一大类具有抗炎、抗菌、抗肿瘤等多种显著生物活性的天然化合物,特别是其抗肿瘤活性吸引了研究者的兴趣,对该类化合物的研究进展较快。本文对2015—2022年倍半萜内酯类化合物抗肿瘤活性及机制的研究进行了归纳总结,为探索倍半萜内酯类化合物抗肿瘤研究提供新的依据和思路。 Malignant tumor is a main threat to human life and health.The research and development of antitumor drugs has always been a hotspots.Natural products are important sources of new drugs.Sesquiterpene lactones inlude many natural compounds with anti-inflammatory,antibacterial,antitumor and other significant biological activities.Their anti-tumor activities have attracted the attention of researchers,and the research progress in these compounds is rapid.This paper summarized to the antitumor activities and mechanisms of sesquiterpene lactones from 2015 to 2022,provide new ideas for exploring anti-tumor studies of sesquiterpene lactones.
作者 林金榕 陈四保 LIN Jin-rong;CHEN Si-bao(Institute of Medicinal Plant Development,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100193)
出处 《中南药学》 2023年第6期1589-1598,共10页 Central South Pharmacy
基金 国家自然科学基金项目(No.81872769)。
关键词 倍半萜内酯 天然产物 抗肿瘤活性 作用机制 sesquiterpene lactone natural product anti-tumor activity mechanism of action
  • 相关文献

参考文献4

二级参考文献26

  • 1刘静明 倪慕云 樊菊芬 等.青蒿素(Arteannuin)的结构和反应.化学学报,1979,:129-143.
  • 2Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008 : GLOBOCAN 2008 [ J]. Int J Cancer,2010, 127 (12) :2893-2917.
  • 3Misra S, Chaturvedi A, Misra NC, et al. Carcinoma of the gallbladder[ J ]. Lancet Oneol,2003,4 (3) : 167-176.
  • 4Caldow Pilgrim CH, Groesehl RT, Quebbeman EJ, et al. Recent advances in systemic therapies and radiotherapy for gallbladder cancer[ J]. Surg Oncol,2013,22( 1 ) :61-67.
  • 5Lu J J, Chert SM, Zhang XW, et al. The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic retieulum stress in eolorectal carcinoma HCT116 cells [ J ]. Invest New Drugs,2011,29 (6) : 1276-1283.
  • 6Chen T, Li M, Zhang R, et al. Dihydroartemisinin induces apuptosis and sensitizes human ovarian cancer cells to carboplatin therapy [J]. J Cell Mol Med,2009,13(7):1358-1370.
  • 7Wang .I, Zhang B, Guo Y, et al. Artemisinin inhibits tumor lymphangiogencsis by suppression of vascular endothelial growth factor C [ J ]. Pharmacology,2008,82 ( 2 ) : 148 -155.
  • 8Sundar SN, Marconett CN, Doan VB, et al. Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells [ J ]. Carcinogenesis,2008,29(12) :2252-2258.
  • 9Weifeng T, Feng S, Xiangii L, et aL Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells [ J]. Phytomedicine,2011,18 (2-3) : 158-162.
  • 10Morrissey C, Gallis B, Solazzi JW, et al. Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells[ J]. Anticancer Drugs,2010,21 ( 4 ) :423 -432.

共引文献1486

同被引文献35

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部